Deutsche Bank Initiates Infinity Pharmaceuticals With Buy By: Benzinga via Benzinga May 07, 2015 at 09:50 AM EDT Analysts at Deutsche Bank initiated coverage on Infinity Pharmaceuticals Inc. (NASDAQ: INFI) with a Buy rating. The target price for ... Read More >> Related Stocks: Infinity Pharmaceuticals